Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ascelia Pharma AB (publ)

ACE
Current price
2.59 SEK +0.02 SEK (+0.78%)
Last closed 2.65 SEK
ISIN SE0010573113
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 263 319 878 SEK
Yield for 12 month +32.29 %
1Y
3Y
5Y
10Y
15Y
ACE
21.11.2021 - 28.11.2021

Ascelia Pharma AB (publ), a biotech company, focuses on orphan oncology treatments in Sweden. The company identifies, develops, and commercializes novel drugs to address unmet needs for rare cancer conditions. It develops Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, that is in Phase 2 trial for the treatment of gastric cancer. Ascelia Pharma AB (publ) was incorporated in 1999 and is based in Malmö, Sweden. Address: Hyllie Boulevard 34, Malmö, Sweden, 215 32

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

101.61 SEK

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-1 062 825 SEK

Last Year

-3 943 277 SEK

Current Quarter

Last Quarter

Key Figures ACE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -57 387 288 SEK
Operating Margin TTM
PE Ratio
Return On Assets TTM -26.48 %
PEG Ratio
Return On Equity TTM -64.84 %
Wall Street Target Price 101.61 SEK
Revenue TTM
Book Value 2.11 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.29 SEK
Diluted Eps TTM -1.29 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ACE

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1340:927
Payout Ratio
Last Split Date 15.08.2024
Dividend Date

Stock Valuation ACE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.391
Price Book MRQ 5.45

Financials ACE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ACE

For 52 weeks

1.91 SEK 18.22 SEK
50 Day MA 2.3 SEK
Shares Short Prior Month
200 Day MA 6.7 SEK
Short Ratio
Shares Short
Short Percent